These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19058849)
21. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942 [TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells. Abraham J; Spaner D; Benchimol S Oncogene; 1999 Feb; 18(8):1521-7. PubMed ID: 10102621 [TBL] [Abstract][Full Text] [Related]
23. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Bozulic L; Surucu B; Hynx D; Hemmings BA Mol Cell; 2008 Apr; 30(2):203-13. PubMed ID: 18439899 [TBL] [Abstract][Full Text] [Related]
24. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context. Wesierska-Gadek J; Gueorguieva M; Komina O; Schmid G; Kramer MP J Cell Biochem; 2008 Apr; 103(5):1607-20. PubMed ID: 17879942 [TBL] [Abstract][Full Text] [Related]
25. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242 [TBL] [Abstract][Full Text] [Related]
26. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. Mukherjee B; Kessinger C; Kobayashi J; Chen BP; Chen DJ; Chatterjee A; Burma S DNA Repair (Amst); 2006 May; 5(5):575-90. PubMed ID: 16567133 [TBL] [Abstract][Full Text] [Related]
27. Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of Friend murine leukemia virus. Hoffman PM; Cimino EF; Robbins DS; Broadwell RD; Powers JM; Ruscetti SK Lab Invest; 1992 Sep; 67(3):314-21. PubMed ID: 1405490 [TBL] [Abstract][Full Text] [Related]
28. Potentiality of DNA-dependent protein kinase to phosphorylate Ser46 of human p53. Komiyama S; Taniguchi S; Matsumoto Y; Tsunoda E; Ohto T; Suzuki Y; Yin HL; Tomita M; Enomoto A; Morita A; Suzuki T; Ohtomo K; Hosoi Y; Suzuki N Biochem Biophys Res Commun; 2004 Oct; 323(3):816-22. PubMed ID: 15381073 [TBL] [Abstract][Full Text] [Related]
29. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033 [TBL] [Abstract][Full Text] [Related]
30. Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector. Kitagawa M; Aizawa S; Kamisaku H; Hirokawa K; Ikeda H Exp Hematol; 1999 Feb; 27(2):234-41. PubMed ID: 10029162 [TBL] [Abstract][Full Text] [Related]
31. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043 [TBL] [Abstract][Full Text] [Related]
32. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339 [TBL] [Abstract][Full Text] [Related]
33. A gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts. Kitagawa M; Aizawa S; Sado T; Yamaguchi S; Suzuki T; Hirokawa K; Ikeda H Leukemia; 2001 Nov; 15(11):1779-84. PubMed ID: 11681421 [TBL] [Abstract][Full Text] [Related]
34. Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors. Abe S; Yamamoto K; Kurata M; Abe-Suzuki S; Horii R; Akiyama F; Kitagawa M Oncotarget; 2015 Oct; 6(33):34892-909. PubMed ID: 26430873 [TBL] [Abstract][Full Text] [Related]
35. Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation. Gurley KE; Ashley AK; Moser RD; Kemp CJ Cell Death Differ; 2017 Nov; 24(11):1853-1860. PubMed ID: 28686579 [TBL] [Abstract][Full Text] [Related]
36. Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia. Yamaguchi S; Kitagawa M; Inoue M; Tejima Y; Kimura M; Aizawa S; Utsuyama M; Hirokawa K Mech Ageing Dev; 2001 Feb; 122(2):219-32. PubMed ID: 11166360 [TBL] [Abstract][Full Text] [Related]
37. Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response. Sun T; Li X; Shen P Oncotarget; 2017 Mar; 8(10):17105-17114. PubMed ID: 28177883 [TBL] [Abstract][Full Text] [Related]
39. Kinetic studies of the effect of a 17-nucleotide difference in the 0.3-kb region containing the R-U5-5' leader sequence of Friend murine leukemia virus on viral gene expression. Choo YC; Seki Y; Takase-Yoden S Microbiol Immunol; 2013 Aug; 57(8):594-9. PubMed ID: 23945025 [TBL] [Abstract][Full Text] [Related]
40. Polyadenylation of Friend murine leukemia virus env-mRNA is affected by its splicing. Machinaga A; Takase-Yoden S Microbiol Immunol; 2014 Aug; 58(8):474-82. PubMed ID: 24935657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]